NovaBay Pharmaceuticals I...

AI Score

0

Unlock

0.59
-0.02 (-3.29%)
At close: Feb 28, 2025, 3:59 PM
0.60
1.68%
After-hours: Feb 28, 2025, 08:00 PM EST

NovaBay Pharmaceuticals Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Revenue 14.73M 14.4M 8.42M 9.93M 6.6M 12.51M 18.23M 11.9M 4.38M 1.05M 3.48M 6.95M 11.02M 9.75M 15.68M 6.72M 5.91M 1.53M n/a n/a n/a
Cost of Revenue 6.83M 6.62M 2.78M 3.97M 1.74M 1.5M 2.78M 2.46M 1.26M 486K 162K 8K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 7.89M 7.78M 5.64M 5.96M 4.86M 11.01M 15.45M 9.43M 3.12M 568K 3.31M 6.94M 11.02M 9.75M 15.68M 6.72M 5.91M 1.53M n/a n/a n/a
Operating Income -5M -7.68M -8.86M -6.43M -9.4M -7.87M -7.31M -10.98M -21.01M -16.88M -15.49M -8.31M -4.32M -4.52M 2.74M -8.51M -5.88M -5.53M -3.57M -2.8M -953K
Interest Income n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income -9.64M -10.61M -5.82M -11.03M -9.65M -6.54M -7.4M -13.15M -18.97M -15.19M -16.04M -7.03M -5.08M -4.26M 2.7M -8.11M -5.39M -5.29M -3.46M n/a -977K
Net Income -9.64M -16.27M -6.56M -11.04M -10.49M -6.54M -7.4M -13.15M -18.97M -15.19M -16.04M -7.03M -5.08M -4.31M 2.7M -8.11M -5.4M -5.29M -3.46M -2.8M -977K
Selling & General & Admin 12.83M 15.29M 14.46M 12.11M 14.08M 18.62M 22.35M 19.04M 18.09M 7.93M 6.34M 5.98M 5.43M 5.65M 5.61M 5.64M 4.37M 2.97M 1.62M n/a n/a
Research & Development 68K 174K 44K 285K 184K 259K 410K 1.37M 6.04M 9.51M 12.46M 9.28M 9.91M 8.62M 7.34M 9.6M 7.42M 4.09M 1.95M n/a 270K
Other Expenses n/a -276K -1.58M 605K -1.43M 19K 12K -68K -96K 22K 1K -155K n/a n/a n/a n/a n/a n/a n/a -2.8M n/a
Operating Expenses 12.9M 15.46M 14.51M 12.39M 14.26M 18.88M 22.76M 20.41M 24.13M 17.45M 18.8M 15.26M 15.34M 14.27M 12.94M 15.23M 11.79M 7.06M 3.57M -2.8M 953K
Interest Expense n/a n/a n/a n/a 1.05M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses 6.5M 7.8M 7.22M 6.17M 8.77M 12.79M 13.71M 11.81M 10.52M 1.75M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 19.73M 22.08M 17.28M 16.36M 16M 20.38M 25.54M 22.88M 25.39M 17.93M 18.96M 15.26M 15.34M 14.27M 12.94M 15.23M 11.79M 7.06M 3.57M -2.8M 953K
Income Tax n/a -3.81M -4.62M 5K 6K 4K 3K 2K 12K 2K 2K 2K 2K 50K 7K 2K 12K -240K -106K 2.8M n/a
Shares Outstanding (Basic) 120.43K 30K 31.64K 28.63K 16.27K 11.6K 12.51K n/a n/a n/a n/a 33.46K 29.45K 26.66K 25.6K 24.36K 10.26K 6.53K 5.54K 5K 4.62K
Shares Outstanding (Diluted) 120.43K 46K 35.63K 28.63K 17.67K 13.93K 12.51K n/a n/a n/a n/a 33.66K 29.45K 26.66K 26.42K 24.36K 10.26K 6.53K 5.54K 5K 4.62K
EPS (Basic) -138.65 -353.59 -184.09 -385.53 -593.63 -473.83 -591.81 n/a n/a n/a n/a -208.8 -172.64 -161.6 105.00 -333.14 -526.52 -809.37 -624.53 -560.46 -211.43
EPS (Diluted) -138.65 -353.59 -184.09 -385.53 -593.63 -564.17 -591.81 n/a n/a n/a n/a -210 -172.64 -161.6 105.00 -333.14 -526.52 -809.37 -624.53 -560.46 -211.43
EBITDA -4.8M -7.2M -8.74M -6.38M -9.34M -7.61M -7.22M -10.87M -20.97M -16.67M -15.17M -7.97M -3.9M -4.09M 3.15M -7.81M -5.21M -5.45M -3.42M -2.8M -929K
Depreciation & Amortization 203K 483K 119K 51K 65K 266K 95K 114K 164K 232K 314K 341K 425K 427K 373K 304K 183K 74K 48K n/a 24K